Immunogenicity and Safety Study of Serum-Free Avonex
NCT00912860
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
DRUG:
Interferon beta-1a
Sponsor
Biogen